Informations: Due to increasing bot activity we were unfortunately forced to place the search behind a login. Links to models can still be shared with others and viewed without a login. Thank you for your understanding.
Informations:
Erreur:
ID
21969
Description
A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone; ODM derived from: https://clinicaltrials.gov/show/NCT00240006
Lien
https://clinicaltrials.gov/show/NCT00240006
Mots-clés
Versions (1)
- 11/05/2017 11/05/2017 -
Téléchargé le
11 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Multiple Sclerosis NCT00240006
Eligibility Multiple Sclerosis NCT00240006
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00240006
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
1. males or females, 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting | Recurrent disease
Item
2. diagnosed with relapsing remitting multiple sclerosis (relapses accepted).
boolean
C0751967 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C0277556 (UMLS CUI [2])
glatiramer acetate | Copaxone
Item
3. beginning or restarting therapy with glatiramer acetate (copaxone®).
boolean
C0289884 (UMLS CUI [1])
C0528175 (UMLS CUI [2])
C0528175 (UMLS CUI [2])
Protocol Compliance
Item
4. willing and able to complete all procedures and evaluations related to the study.
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
5. willing to provide informed consent.
boolean
C0021430 (UMLS CUI [1])
Biological Response Modifiers | Therapeutic immunosuppression | Copaxone
Item
1. taking any other immunomodulatory or immunosuppressant therapy in conjunction with copaxone®.
boolean
C0005525 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C0528175 (UMLS CUI [3])
C0021079 (UMLS CUI [2])
C0528175 (UMLS CUI [3])
Illness Interferes with Endpoints Assessment | Multiple Sclerosis | Illness Interferes with Study Subject Participation Status
Item
2. has a significant medical illness other than ms that may interfere with the assessment of endpoints or the subject's participation in the trial for the full duration of the study.
boolean
C0221423 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0026769 (UMLS CUI [2])
C0221423 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0026769 (UMLS CUI [2])
C0221423 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
Condition Interferes with Study Subject Participation Status
Item
3. any situation that the investigator or nurse (if not the investigator) feel may interfere with participation in the study.
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
4. pregnant or trying to become pregnant, or breast feeding during the study.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Study Subject Participation Status
Item
5. previously participated in this study or another clinical research study in the past 30 days.
boolean
C2348568 (UMLS CUI [1])